Inspirna
Dr. Rowinsky is principally focused on the comprehensive development and registration strategies of cancer therapeutics of all types. Dr. Rowinsky obtained his B.A. degree from New York University and his M.D. from the Vanderbilt University School of Medicine. Following his residency in internal medicine at the University of California, he completed fellowship training in medical oncology and clinical pharmacology at the Johns Hopkins University School of Medicine.
This person is not in the org chart
This person is not in any offices
Inspirna
Inspirna, Inc. (formerly known as Rgenix, Inc.) is developing first-in-class drugs that target key pathways in cancer progression.